New York State Common Retirement Fund Durect Corp Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.38 - $0.64 $49,780 - $83,840	-131,000 Reduced 98.48%	2,027 $1,000
Q4 2021 Feb 02, 2022	SELL	$0.9 - $1.31 $251 - $365	-279 Reduced 0.21%	133,027 $131,000
Q3 2021 Nov 02, 2021	SELL	$1.21 - $1.61 $59,977 - $79,804	-49,568 Reduced 27.11%	133,306 $171,000
Q2 2021 Aug 02, 2021	BUY	$1.6 - $2.02 $2,838 - $3,583	1,774 Added 0.98%	182,874 $298,000
Q2 2020 Aug 07, 2020	BUY	$1.33 - $2.76 $240,863 - $499,835	181,100 New	181,100 $420,000
Q2 2019 Aug 09, 2019	SELL	$0.51 - $0.86 $76,296 - $128,656	-149,600 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$1.56 - $2.51 $73,788 - $118,722	47,300 Added 46.24%	149,600 $233,000
Q2 2017 Aug 11, 2017	BUY	N/A	102,300	102,300 $160,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.